Neuland Laboratories Ltd News
Neuland Labs gets capex nod lift; stock up 5% even as broader indices sink
The company said it will spend Rs 254 crore for development and commercial production of Peptides for Generic Drug Substances (GDS) and Custom Manufacturing Solutions (CMS) business.
 "Neuland Labs gets capex nod lift; stock up 5% even as broader indices sink")
Why Neuland Laboratories shares fall 7% in trade? check reasons here
As per reports, Smallcap World Fund was planning to sell a 3.8 percent stake in the Neuland Laboratories through a block deal
 "Why Neuland Laboratories shares fall 7% in trade? check reasons here")
CDMO shares under pressure; Neuland, Laurus, Syngene tank up to 12%
Thus far in the calendar year 2024 (CY24), the market price of Neuland Laboratories has zoomed 216%, Piramal Pharma (88%), Divi's Labs (53%) and Jubilant Pharmova (52%)
 "CDMO shares under pressure; Neuland, Laurus, Syngene tank up to 12%")
This Mukul Agrawal portfolio stock slipped 15% after 164% rally in 5 months
The management said the inherent uneven nature of the company's business means that annual progression is a better indicator of the company's prospects than quarterly performance
 "This Mukul Agrawal portfolio stock slipped 15% after 164% rally in 5 months")
Mukul Agrawal portfolio stock zooms 122% in 4 months; up 1100% in 25 months
Investor Mukul Mahavir Agrawal held 400,000 shares, representing 3.12 per cent stake, in Neuland Lab at the end of June quarter, shareholding pattern data shows
 "Mukul Agrawal portfolio stock zooms 122% in 4 months; up 1100% in 25 months")
This Mukul Agrawal-owned stock crossed Rs 10,000-mark; up 725% in 2 years
Neuland Laboratories hit a new high of Rs 11,093.15, as the stock rallied 18% on the BSE in Friday's intra-day trade on the back of robust earnings for June 2024 quarter.
